Health information to help you understand symptoms. It isn't a diagnosis.
Check symptoms

Research deep dives

HLA-DRB1*15:01: the gene variant behind much of MS risk, study by study

Last reviewed November 15, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.

HLA genes give the immune system its 'ID card readers.' They make proteins that sit on the outside of immune cells and show small pieces of germs (and sometimes of our own body) to other immune cells, which then decide whether to attack.

Everyone has HLA genes, but they come in thousands of versions. One version, called HLA-DRB1*15:01 (sometimes written HLA-DR15 or DR2), is the single strongest genetic risk factor for multiple sclerosis. Below we follow how scientists found it, how big its effect is, where it came from, and how it may work together with the Epstein-Barr virus.

Related pages: Multiple sclerosis (MS) · Epstein-Barr virus (EBV) infection

The bottom line

What we know
  • HLA-DRB1*15:01 is the strongest single genetic risk factor for MS. Each copy roughly triples the odds of getting it.
  • It's common: many people of Northern European ancestry carry it, and most of them never get MS.
  • Genes are only part of the story. More than 230 gene variants each add a little risk, and infection with Epstein-Barr virus, low vitamin D, smoking, and teenage obesity also matter.
What is still open
  • Exactly how the variant leads to MS. A 2026 study showed one way it may work with Epstein-Barr virus, but it was mainly done in the lab.
  • Why the variant became common in Europe. Ancient DNA suggests it once helped fight infections, but that's a theory.
  • Whether knowing someone carries it will ever change how MS is prevented or treated. There's no reason to get tested for it today.

The studies, in order

  1. 1. The first clue (Jersild and others, Denmark, 1972 to 1973; Naito and others, US, 1972)
  2. 2. Pinning it down (International Multiple Sclerosis Genetics Consortium, 2015)
  3. 3. The whole genome (International Multiple Sclerosis Genetics Consortium, 2019)
  4. 4. Ancient DNA (Barrie and others, 2024)
  5. 5. Teaming up with EBV (Wang, Martin, and others, 2026)
What the evidence labels mean
GuidelineAn official recommendation from an expert group after weighing all the evidence.
Review of many studiesCombines the results of many studies (a systematic review or meta-analysis).
Randomized trialPeople were randomly given a treatment or a comparison, the best way to test cause and effect.
Large observational studyFollows many people over time. Shows strong links, but not always cause and effect.
Small or early studyA small study, case series, or first results. Needs to be confirmed.
Lab or animal studyDone in cells or animals. May not apply to people.
Study 1 of 5

MS was linked to immune 'ID card' genes in the 1970s

Jersild and others, Denmark, 1972 to 1973; Naito and others, US, 1972The Lancet and Tissue AntigensSmall or early study

What they did

Doctors had just learned to type people's HLA markers (the same markers used to match organ transplants). Teams in Denmark and the US compared these markers in people with and without MS.

What they found

  • Some HLA types, first called HLA-A3 and HLA-B7, and soon after a type called Dw2 (later DR2), were more common in people with MS.
  • The strongest link turned out to be with the DR2 group, which later work narrowed down to HLA-DRB1*15:01.

What it means

This was the first sign that inherited immune genes help decide who gets MS.

What it can't tell us

  • The tests of that era were crude and the groups were small.
  • These early markers sit near each other on the same piece of DNA, so it wasn't yet clear which gene mattered.

Read it yourself

Next: Pinning it down

Study 2 of 5

One version, HLA-DRB1*15:01, carries most of the HLA risk

International Multiple Sclerosis Genetics Consortium, 2015Nature GeneticsLarge observational study

What they did

Researchers compared the HLA genes of 17,465 people with MS and 30,385 people without MS, all of European ancestry.

What they found

  • HLA-DRB1*15:01 had by far the biggest effect: one copy raised the odds of MS about 3.9-fold.
  • Two copies (one from each parent) raised the odds about 8-fold.
  • Other HLA versions added smaller risks, and one, HLA-A*02:01, seemed to protect a little.

What it means

Within the HLA region, HLA-DRB1*15:01 is the main player. Other nearby genes mostly 'ride along' with it.

What it can't tell us

  • Odds ratios describe risk in groups. Since MS is uncommon, even 3 to 8 times the odds still means most carriers never get MS.
  • The study included only people of European ancestry.

Read it yourself

Next: The whole genome

Study 3 of 5

More than 230 gene variants add to MS risk

International Multiple Sclerosis Genetics Consortium, 2019ScienceLarge observational study

What they did

The largest MS genetics study so far compared the DNA of 47,429 people with MS and 68,374 people without it.

What they found

  • 233 separate places in our DNA were linked to MS. 32 are in the HLA region, and one is on the X chromosome.
  • Together they explain about half of MS's inherited risk.
  • Many of the genes work in immune cells in the blood and in microglia, the brain's own immune cells.

What it means

MS isn't caused by one gene. HLA-DRB1*15:01 is the biggest single piece, sitting on top of hundreds of small ones.

What it can't tell us

  • Most participants were of European ancestry.
  • Finding a gene variant doesn't tell us exactly what it does.

Read it yourself

Next: Ancient DNA

Study 4 of 5

The risk rose among Bronze Age herders about 5,000 years ago

Barrie and others, 2024Nature (part of a large ancient-DNA project)Small or early study

What they did

Scientists read DNA from ancient bones and teeth across Europe and western Asia, as part of a project that analyzed about 5,000 ancient human genomes, the oldest about 34,000 years old. They compared them with DNA from about 400,000 people living today in the UK Biobank.

What they found

  • Gene variants that raise MS risk, including HLA-DRB1*15:01, became common among herders on the Pontic steppe (now Ukraine and southern Russia).
  • These herders, linked to the Yamnaya culture, carried the variants into Europe when they migrated about 5,000 years ago.
  • The variants were favored by natural selection, probably because they helped fight infections at a time of big changes in diet, lifestyle, and living close to livestock.

What it means

This helps explain why MS is most common in Northern Europe, where steppe ancestry is highest. It's covered in more detail in our page on the origin of MS.

What it can't tell us

  • Ancient DNA shows when and where variants became common, not exactly why. The infection idea is a strong theory, not proven.
  • It mainly studied people of European ancestry.

Read it yourself

Next: Teaming up with EBV

Study 5 of 5

With the mono virus, HLA-DR15 may teach the immune system to attack myelin

Wang, Martin, and others, 2026CellLab or animal study

What they did

Researchers studied B cells infected with Epstein-Barr virus (EBV) from people who carry HLA-DR15, the group that includes HLA-DRB1*15:01. They also looked at brain tissue from people with MS and at immune cells from their blood and spinal fluid.

What they found

  • EBV changed which protein pieces the infected B cells displayed on their HLA-DR15 'ID card readers.'
  • The infected cells showed pieces of myelin basic protein, part of the coating around nerves. Uninfected B cells did not.
  • The same myelin pieces were found on HLA-DR15 in MS brain tissue, and immune T cells from people with MS reacted to them.

What it means

This offers one explanation for how the strongest gene risk and the strongest environmental risk for MS could work together: EBV infection plus HLA-DR15 may point the immune system at myelin.

What it can't tell us

  • Much of the work used lab-grown infected cell lines, which may not fully match infected cells in the body.
  • It's one study and needs to be confirmed by other teams.

Read it yourself

More plain-language reading

See something wrong or unclear on this page? Suggest a correction. OwieClear is for education only and isn't medical advice.